SESSION 2: DIRECT-TO-CONSUMER NEUROTECHNOLOGY
DR. WAGNER: Let me welcome all of our Commissioners back. And who are we waiting for? Steve.
DR. GUTMANN: Let's just get started. We can get started. People will come very quickly when you ‑‑ once you get started.
DR. WAGNER: Steve and John are out in the hallway. And ‑‑ are they just chatting? Here comes John.
DR. GUTMANN: May I ask everybody to please take his or her seat? Appreciate it. We're going to get started.
Good morning. I am Amy Gutmann. I am President of the University of Pennsylvania, and I'm Chair of the Presidential Commission for the Study of Bioethical Issues. And on behalf of myself and our Vice‑Chair Jim Wagner, who is the President of Emory University, I would like to welcome you to our 18th meeting.
DR. WAGNER: And I think we move on without a break at this point. So let me ask Dr. Lin and Dr. McGinn to come forward. They are going to help advise us and help us discuss frameworks for evaluating ethical and societal issues raised by emerging technologies. So we are still talking about DSLRs, I guess, in a sense.
DR. GUTMANN: Welcome back. Thank you again. We have a roundtable now, and, as is our tradition, we want to get input from you as to what you think is the single most important issue that we should deal with, whether it be a finding or recommendation in our report.
DR. GUTMANN: Good morning, everybody, and welcome back. I am Amy Gutmann. I am President of the University of Pennsylvania and Chair of the President's Commission for the Study of Bioethical Issues. On behalf of myself and our Vice-Chair, Jim Wagner, who is the President of Emory University and has been a terrific host to us for these two days. I welcome everyone to the second day of our 17th meeting.
DR. WAGNER: This session also we have four presenters to hear from, this time focusing on the potential of neuroscience research in clinical applications. Thank the four of you for joining us. As before I'll introduce you one at a time as you make your remarks, and we will hold the Q and A until all four have presented.
DR. GUTMANN: Our next session will focus on data sharing and access in neuroscience. This is an issue we've been keenly interested in. We will hear from Dr. Giorgio Ascoli. Dr. Ascoli is University Professor in the Molecular Neuroscience Department and Founding Director of the Center for Neural Informatics at Krasnow Institute for Advanced Study of George Mason University. He created and curates NeuroMorpho.org, a publicly accessible collection of three-dimensional digital reconstructions of neurons. Dr.
DR. WAGNER: Let me ask our guests to come forward, Professor Dresser and Drs. Graf, Wright, and Feldman, if you could come forward to the table here while we get underway. Commissioners, I'm imagining that in order that we can hear fully from all of our guests this morning, we may have a short lunch this afternoon, and that will be just fine.
DR. GUTMANN: Welcome, everybody. It's great to be in Atlanta. It's great to be at the CDC. It's great to be hosted by the President of Emory University, Jim Wagner. I want to say thank you to Jim. He is not only a great host of this meeting but a great Vice-Chair of this commission. And good morning to my fellow commission members.
This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply